All enrolled people who been given at the very least one particular dose of zosuquidar or placebo all through induction were being monitored for that incidence of adverse functions (439 individuals, 219 on zosuquidar and 210 on placebo). The most common adverse events were being relevant to the duration of https://joshv221mzj4.activoblog.com/profile